The MDA MB-231 sgRNA1 & 2 cell line contains site-specific methylations in the BRCA1 promoter, analogous to the sites of methylation in breast cancer patients.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.